Everself is building the first true medical brand for obesity care.

Obesity is one of the largest and most undertreated categories in healthcare. Care today remains fragmented across telemedicine, GLP-1 prescribing with limited clinical support, invasive bariatric surgery, and a small number of academic centers offering advanced procedural care. This creates an opportunity to build the category-defining platform for long-term weight care: a trusted national brand combining leading physicians, scalable care infrastructure, and a growing portfolio of advanced minimally invasive procedures.

Led by two renowned Harvard Medical School physician-researchers, Dr. Chris Thompson and Sigh Jirapinyo and CEO Petch Jirapinyo, Everself has become the largest provider of endoscopic weight care in North America. Their flagship offering, ESG Stomach Tightening, is a one-hour outpatient procedure that delivers an average weight loss of 18% (patients losing 60–140+ lbs), a compelling next step for the 1.5M U.S. adults leaving GLP-1s each month. One of the co-founders, Dr. Christopher Thompson, invented the procedure.

BrandProject led Everself’s seed round in 2025.